| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.888 | 0.004 | 0.888 | Cardiotonic | 0.438 0.023 DBMET02836 0.872 0.004 DBMET02838 0.864 0.004 DBMET02839 0.882 0.004 DBMET02840 0.852 0.004 DBMET02842 0.863 0.004 DBMET02843 0.786 0.004 DBMET02841 0.785 0.004 DBMET02844 | ||
| 0.72 | 0.007 | 0.89 | Aldehyde oxidase inhibitor | 0.89 0.003 DBMET02836 0.521 0.03 DBMET02838 0.568 0.023 DBMET02839 0.853 0.004 DBMET02840 0.718 0.007 DBMET02842 0.735 0.006 DBMET02843 0.378 0.05 DBMET02841 0.346 0.056 DBMET02844 | DBMET02836 | |
| 0.685 | 0.005 | 0.685 | Vasodilator, coronary | 0.635 0.006 DBMET02836 0.66 0.005 DBMET02838 0.575 0.009 DBMET02839 0.496 0.016 DBMET02840 0.508 0.014 DBMET02842 0.536 0.011 DBMET02843 0.409 0.032 DBMET02841 0.463 0.021 DBMET02844 | ||
| 0.489 | 0.035 | 0.489 | Thyroid hormone antagonist | 0.34 0.077 DBMET02836 0.371 0.066 DBMET02838 0.335 0.079 DBMET02839 0.39 0.059 DBMET02840 0.458 0.041 DBMET02842 0.357 0.071 DBMET02843 | ||
| 0.477 | 0.036 | 0.477 | Thyroid hormone beta antagonist | 0.29 0.093 DBMET02836 0.363 0.064 DBMET02838 0.298 0.089 DBMET02839 0.385 0.058 DBMET02840 0.439 0.043 DBMET02842 0.35 0.069 DBMET02843 | ||
| 0.39 | 0.025 | 0.407 | Vasodilator | 0.407 0.022 DBMET02836 0.367 0.029 DBMET02838 0.353 0.032 DBMET02839 0.328 0.039 DBMET02840 0.38 0.027 DBMET02842 0.363 0.03 DBMET02843 0.228 0.084 DBMET02841 0.295 0.05 DBMET02844 | DBMET02836 | |
| 0.376 | 0.016 | 0.448 | Non-steroidal antiinflammatory agent | 0.302 0.028 DBMET02836 0.276 0.034 DBMET02838 0.325 0.023 DBMET02839 0.421 0.011 DBMET02840 0.448 0.009 DBMET02842 0.409 0.013 DBMET02843 0.388 0.015 DBMET02841 0.325 0.023 DBMET02844 | DBMET02842 | |
| 0.364 | 0.029 | 0.364 | Potassium channel blocker | 0.294 0.049 DBMET02838 0.265 0.059 DBMET02839 0.206 0.089 DBMET02840 0.24 0.071 DBMET02843 | ||
| 0.342 | 0.045 | 0.386 | Sodium/bile acid cotransporter inhibitor | 0.368 0.03 DBMET02836 0.346 0.042 DBMET02838 0.329 0.054 DBMET02839 0.379 0.024 DBMET02840 0.386 0.022 DBMET02842 0.361 0.033 DBMET02843 0.371 0.028 DBMET02841 0.374 0.027 DBMET02844 | DBMET02842 | |
| 0.298 | 0.003 | 0.431 | Beta adrenoreceptor antagonist | 0.131 0.008 DBMET02836 0.431 0.002 DBMET02838 0.241 0.003 DBMET02839 0.233 0.003 DBMET02840 0.211 0.004 DBMET02842 0.292 0.003 DBMET02843 0.087 0.022 DBMET02841 0.152 0.006 DBMET02844 | DBMET02838 | |
| 0.283 | 0.005 | 0.378 | Uric acid excretion stimulant | 0.138 0.028 DBMET02836 0.273 0.005 DBMET02838 0.286 0.005 DBMET02839 0.378 0.004 DBMET02840 0.355 0.004 DBMET02842 0.341 0.004 DBMET02843 0.288 0.005 DBMET02841 0.266 0.006 DBMET02844 | DBMET02840 | |
| 0.289 | 0.021 | 0.379 | Protein-tyrosine phosphatase inhibitor | 0.205 0.045 DBMET02836 0.292 0.02 DBMET02838 0.285 0.022 DBMET02839 0.379 0.01 DBMET02840 0.367 0.011 DBMET02842 0.317 0.016 DBMET02843 0.295 0.02 DBMET02841 0.272 0.025 DBMET02844 | DBMET02840 | |
| 0.309 | 0.047 | 0.309 | Potassium channel (Voltage-sensitive) blocker | 0.245 0.07 DBMET02838 0.233 0.076 DBMET02839 0.192 0.101 DBMET02840 0.209 0.09 DBMET02843 | ||
| 0.231 | 0.004 | 0.269 | Beta 3 adrenoreceptor antagonist | 0.153 0.005 DBMET02836 0.269 0.003 DBMET02838 0.14 0.007 DBMET02839 0.179 0.004 DBMET02840 0.138 0.007 DBMET02842 0.17 0.005 DBMET02843 0.06 0.057 DBMET02841 0.071 0.032 DBMET02844 | DBMET02838 | |
| 0.243 | 0.018 | 0.325 | Protein-tyrosine phosphatase 1B inhibitor | 0.161 0.041 DBMET02836 0.245 0.018 DBMET02838 0.235 0.02 DBMET02839 0.325 0.009 DBMET02840 0.32 0.009 DBMET02842 0.264 0.014 DBMET02843 0.254 0.016 DBMET02841 0.237 0.019 DBMET02844 | DBMET02840 | |
| 0.243 | 0.035 | 0.369 | Thrombolytic | 0.193 0.055 DBMET02836 0.258 0.031 DBMET02838 0.306 0.023 DBMET02839 0.269 0.029 DBMET02840 0.298 0.024 DBMET02842 0.275 0.028 DBMET02843 0.369 0.014 DBMET02841 0.248 0.034 DBMET02844 | DBMET02841 | |
| 0.225 | 0.019 | 0.225 | Alpha 2b adrenoreceptor antagonist | 0.211 0.021 DBMET02838 0.134 0.048 DBMET02839 0.16 0.035 DBMET02840 | ||
| 0.291 | 0.094 | 0.543 | Antithrombotic | 0.543 0.023 DBMET02836 0.274 0.108 DBMET02838 0.294 0.092 DBMET02839 0.283 0.101 DBMET02840 0.388 0.052 DBMET02842 0.263 0.116 DBMET02843 0.364 0.059 DBMET02841 0.503 0.029 DBMET02844 | DBMET02836 | |
| 0.259 | 0.063 | 0.259 | HERG channel blocker | 0.19 0.097 DBMET02838 0.192 0.096 DBMET02839 0.15 0.131 DBMET02840 0.162 0.118 DBMET02843 | ||
| 0.174 | 0.005 | 0.249 | Plasminogen activator inhibitor antagonist | 0.102 0.01 DBMET02836 0.164 0.005 DBMET02838 0.175 0.005 DBMET02839 0.212 0.004 DBMET02840 0.249 0.004 DBMET02842 0.224 0.004 DBMET02843 0.181 0.004 DBMET02841 0.229 0.004 DBMET02844 | DBMET02842 | |
| 0.185 | 0.021 | 0.238 | MAP kinase kinase 4 inhibitor | 0.19 0.018 DBMET02838 0.193 0.017 DBMET02839 0.238 0.006 DBMET02840 0.188 0.019 DBMET02842 0.204 0.012 DBMET02843 0.178 0.025 DBMET02841 0.173 0.03 DBMET02844 | DBMET02840 | |
| 0.284 | 0.125 | 0.316 | Calpain 2 inhibitor | 0.316 0.104 DBMET02836 0.309 0.109 DBMET02838 0.28 0.128 DBMET02840 | DBMET02836 | |
| 0.198 | 0.043 | 0.466 | Phospholipase A2 inhibitor | 0.466 0.004 DBMET02836 0.186 0.05 DBMET02838 0.201 0.042 DBMET02839 0.168 0.06 DBMET02840 0.339 0.009 DBMET02842 0.255 0.022 DBMET02843 0.145 0.079 DBMET02844 | DBMET02836 | |
| 0.161 | 0.012 | 0.243 | Adrenaline agonist | 0.149 0.015 DBMET02836 0.243 0.005 DBMET02838 0.136 0.019 DBMET02839 0.182 0.009 DBMET02840 0.146 0.016 DBMET02842 0.146 0.015 DBMET02843 | DBMET02838 | |
| 0.234 | 0.087 | 0.371 | Hypoglycemic | 0.335 0.041 DBMET02836 0.251 0.076 DBMET02838 0.257 0.073 DBMET02839 0.266 0.068 DBMET02840 0.332 0.042 DBMET02842 0.301 0.052 DBMET02843 0.356 0.036 DBMET02841 0.371 0.033 DBMET02844 | DBMET02844 | |
| 0.188 | 0.047 | 0.292 | Cyclooxygenase inhibitor | 0.181 0.05 DBMET02838 0.186 0.048 DBMET02839 0.292 0.018 DBMET02840 0.237 0.029 DBMET02842 0.249 0.027 DBMET02843 0.167 0.058 DBMET02841 0.153 0.067 DBMET02844 | DBMET02840 | |
| 0.153 | 0.017 | 0.199 | ABCA1 expression enhancer | 0.199 0.009 DBMET02836 0.137 0.021 DBMET02838 0.136 0.022 DBMET02839 0.133 0.023 DBMET02840 0.158 0.015 DBMET02842 0.141 0.02 DBMET02843 0.116 0.034 DBMET02841 0.116 0.033 DBMET02844 | DBMET02836 | |
| 0.139 | 0.008 | 0.182 | Elastase 1 inhibitor | 0.139 0.008 DBMET02838 0.138 0.008 DBMET02839 0.182 0.004 DBMET02840 0.16 0.005 DBMET02842 0.147 0.007 DBMET02843 0.124 0.011 DBMET02841 0.114 0.014 DBMET02844 | DBMET02840 | |
| 0.292 | 0.17 | 0.545 | Cyclophilin D inhibitor | 0.334 0.135 DBMET02836 0.337 0.132 DBMET02838 0.323 0.143 DBMET02839 0.362 0.114 DBMET02840 0.492 0.053 DBMET02842 0.448 0.068 DBMET02843 0.517 0.045 DBMET02841 0.545 0.039 DBMET02844 | DBMET02844 | |
| 0.224 | 0.103 | 0.619 | Spasmolytic | 0.619 0.011 DBMET02836 0.165 0.15 DBMET02838 | DBMET02836 | |
| 0.161 | 0.041 | 0.543 | Aldehyde dehydrogenase inhibitor | 0.543 0.004 DBMET02836 0.147 0.049 DBMET02838 0.186 0.031 DBMET02839 0.228 0.022 DBMET02840 0.254 0.017 DBMET02842 0.266 0.015 DBMET02843 | DBMET02836 | |
| 0.165 | 0.049 | 0.27 | Cyclooxygenase 1 inhibitor | 0.156 0.054 DBMET02838 0.162 0.051 DBMET02839 0.27 0.018 DBMET02840 0.214 0.029 DBMET02842 0.209 0.031 DBMET02843 0.145 0.059 DBMET02841 0.138 0.064 DBMET02844 | DBMET02840 | |
| 0.155 | 0.05 | 0.239 | Cyclooxygenase 2 inhibitor | 0.152 0.053 DBMET02838 0.153 0.052 DBMET02839 0.239 0.022 DBMET02840 0.192 0.033 DBMET02842 0.205 0.029 DBMET02843 0.139 0.063 DBMET02841 0.124 0.075 DBMET02844 | DBMET02840 | |
| 0.112 | 0.008 | 0.16 | Beta 1 adrenoreceptor antagonist | 0.099 0.01 DBMET02836 0.16 0.004 DBMET02838 0.093 0.012 DBMET02839 0.097 0.011 DBMET02840 0.085 0.015 DBMET02842 0.117 0.007 DBMET02843 0.052 0.044 DBMET02844 | DBMET02838 | |
| 0.133 | 0.033 | 0.144 | Electron transport complex I inhibitor | 0.121 0.045 DBMET02836 0.134 0.032 DBMET02838 0.121 0.046 DBMET02839 0.144 0.024 DBMET02840 0.128 0.037 DBMET02842 0.141 0.026 DBMET02843 0.12 0.048 DBMET02841 0.108 0.067 DBMET02844 | DBMET02840 | |
| 0.151 | 0.057 | 0.222 | Calcium channel blocker | 0.222 0.023 DBMET02836 0.139 0.069 DBMET02838 | DBMET02836 | |
| 0.132 | 0.041 | 0.175 | Nav1.1 sodium channel blocker | 0.175 0.025 DBMET02836 0.101 0.065 DBMET02838 0.095 0.073 DBMET02839 0.088 0.084 DBMET02843 | DBMET02836 | |
| 0.131 | 0.042 | 0.197 | Antiadrenergic | 0.197 0.025 DBMET02838 0.097 0.057 DBMET02839 0.092 0.061 DBMET02840 0.097 0.057 DBMET02843 | DBMET02838 | |
| 0.162 | 0.073 | 0.182 | Interleukin 6 antagonist | 0.159 0.076 DBMET02836 0.153 0.085 DBMET02838 0.16 0.075 DBMET02839 0.149 0.091 DBMET02840 0.137 0.11 DBMET02842 0.149 0.09 DBMET02843 0.182 0.053 DBMET02841 | DBMET02841 | |
| 0.09 | 0.007 | 0.102 | Vanilloid 2 antagonist | 0.054 0.032 DBMET02836 0.087 0.007 DBMET02838 0.083 0.009 DBMET02839 0.102 0.005 DBMET02840 0.081 0.009 DBMET02842 0.085 0.008 DBMET02843 0.066 0.017 DBMET02841 0.064 0.019 DBMET02844 | DBMET02840 | |
| 0.091 | 0.009 | 0.145 | Beta 2 adrenoreceptor antagonist | 0.082 0.011 DBMET02836 0.145 0.005 DBMET02838 0.082 0.011 DBMET02839 0.086 0.01 DBMET02840 0.073 0.015 DBMET02842 0.082 0.011 DBMET02843 | DBMET02838 | |
| 0.171 | 0.089 | 0.209 | P-glycoprotein inhibitor | 0.209 0.058 DBMET02836 0.164 0.097 DBMET02838 0.14 0.132 DBMET02839 0.146 0.124 DBMET02840 0.148 0.12 DBMET02842 0.16 0.102 DBMET02843 0.185 0.075 DBMET02844 | DBMET02836 | |
| 0.103 | 0.023 | 0.211 | Calcium channel L-type blocker | 0.211 0.005 DBMET02836 0.083 0.036 DBMET02838 | DBMET02836 | |
| 0.209 | 0.131 | 0.428 | Lipoxygenase inhibitor | 0.24 0.107 DBMET02836 0.217 0.124 DBMET02838 0.235 0.111 DBMET02839 0.428 0.031 DBMET02840 0.419 0.033 DBMET02842 0.361 0.048 DBMET02843 0.233 0.112 DBMET02844 | DBMET02840 | |
| 0.159 | 0.085 | 0.191 | Antipruritic | 0.191 0.056 DBMET02836 0.169 0.075 DBMET02838 0.186 0.059 DBMET02839 0.168 0.075 DBMET02840 0.137 0.111 DBMET02843 | DBMET02836 | |
| 0.087 | 0.016 | 0.193 | Thromboxane antagonist | 0.092 0.014 DBMET02836 0.097 0.012 DBMET02838 0.062 0.031 DBMET02839 0.102 0.01 DBMET02840 0.193 0.004 DBMET02842 0.102 0.01 DBMET02843 0.083 0.018 DBMET02841 0.086 0.017 DBMET02844 | DBMET02842 | |
| 0.084 | 0.013 | 0.186 | Thromboxane A2 antagonist | 0.082 0.014 DBMET02836 0.092 0.009 DBMET02838 0.065 0.025 DBMET02839 0.096 0.008 DBMET02840 0.186 0.003 DBMET02842 0.095 0.009 DBMET02843 0.081 0.014 DBMET02841 0.083 0.014 DBMET02844 | DBMET02842 | |
| 0.115 | 0.046 | 0.184 | Adrenaline antagonist | 0.184 0.027 DBMET02838 0.087 0.063 DBMET02839 0.082 0.067 DBMET02840 0.088 0.062 DBMET02843 | DBMET02838 | |
| 0.196 | 0.135 | 0.221 | 5 Hydroxytryptamine 1E antagonist | 0.221 0.107 DBMET02836 0.169 0.167 DBMET02838 0.17 0.166 DBMET02840 | DBMET02836 | |
| 0.074 | 0.014 | 0.087 | Beta 2 adrenoreceptor agonist | 0.079 0.01 DBMET02836 0.087 0.006 DBMET02838 0.068 0.023 DBMET02839 0.075 0.013 DBMET02840 0.06 0.049 DBMET02842 0.068 0.023 DBMET02843 | DBMET02838 | |
| 0.063 | 0.007 | 0.092 | Beta adrenoreceptor agonist | 0.067 0.006 DBMET02836 0.092 0.004 DBMET02838 0.054 0.012 DBMET02839 0.066 0.006 DBMET02840 0.061 0.008 DBMET02842 0.058 0.009 DBMET02843 0.043 0.039 DBMET02844 | DBMET02838 | |
| 0.093 | 0.043 | 0.178 | Histamine H2 receptor antagonist | 0.178 0.006 DBMET02836 0.1 0.035 DBMET02838 0.079 0.066 DBMET02839 | DBMET02836 | |
| 0.053 | 0.008 | 0.15 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.124 0.004 DBMET02836 0.035 0.023 DBMET02838 0.046 0.012 DBMET02839 0.043 0.013 DBMET02840 0.15 0.003 DBMET02842 0.052 0.008 DBMET02843 | DBMET02842 | |
| 0.123 | 0.082 | 0.187 | Bone formation stimulant | 0.187 0.039 DBMET02836 0.124 0.082 DBMET02838 0.128 0.078 DBMET02839 0.116 0.089 DBMET02840 0.134 0.073 DBMET02842 0.146 0.062 DBMET02843 | DBMET02836 | |
| 0.106 | 0.068 | 0.106 | Multidrug resistance-associated protein 1 inhibitor | 0.093 0.092 DBMET02836 0.099 0.081 DBMET02838 0.097 0.084 DBMET02839 0.103 0.072 DBMET02840 | ||
| 0.148 | 0.11 | 0.491 | Phospholipase C inhibitor | 0.491 0.006 DBMET02836 0.147 0.113 DBMET02838 0.165 0.08 DBMET02839 0.176 0.065 DBMET02840 0.165 0.08 DBMET02842 0.162 0.085 DBMET02843 0.153 0.099 DBMET02841 0.173 0.069 DBMET02844 | DBMET02836 | |
| 0.039 | 0.004 | 0.056 | Thyroid hormone alpha antagonist | 0.02 0.008 DBMET02836 0.027 0.005 DBMET02838 0.026 0.005 DBMET02839 0.044 0.004 DBMET02840 0.056 0.004 DBMET02842 0.034 0.005 DBMET02843 0.023 0.006 DBMET02841 0.02 0.007 DBMET02844 | DBMET02842 | |
| 0.054 | 0.027 | 0.066 | Alpha 1b adrenoreceptor agonist | 0.054 0.027 DBMET02838 0.054 0.027 DBMET02839 0.066 0.014 DBMET02840 0.051 0.032 DBMET02842 0.055 0.026 DBMET02843 | DBMET02840 | |
| 0.056 | 0.031 | 0.07 | 5 Hydroxytryptamine 1B agonist | 0.07 0.018 DBMET02836 0.054 0.035 DBMET02838 0.06 0.027 DBMET02839 | DBMET02836 | |
| 0.128 | 0.104 | 0.163 | Pregnane X receptor agonist | 0.16 0.037 DBMET02840 0.131 0.096 DBMET02842 0.163 0.033 DBMET02843 | DBMET02843 | |
| 0.044 | 0.022 | 0.126 | Dihydropteroate synthase inhibitor | 0.126 0.004 DBMET02836 0.049 0.017 DBMET02838 0.048 0.019 DBMET02839 0.04 0.027 DBMET02840 0.048 0.019 DBMET02842 | DBMET02836 | |
| 0.07 | 0.049 | 0.153 | Peroxisome proliferator-activated receptor gamma agonist | 0.153 0.012 DBMET02836 0.064 0.054 DBMET02838 0.06 0.058 DBMET02839 0.124 0.019 DBMET02842 0.135 0.016 DBMET02843 0.104 0.026 DBMET02844 | DBMET02836 | |
| 0.039 | 0.019 | 0.048 | AMPA receptor agonist | 0.038 0.02 DBMET02838 0.044 0.014 DBMET02839 0.048 0.01 DBMET02840 0.046 0.012 DBMET02842 0.043 0.015 DBMET02843 0.04 0.018 DBMET02841 0.033 0.03 DBMET02844 | DBMET02840 | |
| 0.155 | 0.139 | 0.281 | Free radical scavenger | 0.19 0.106 DBMET02836 0.162 0.132 DBMET02838 0.155 0.14 DBMET02839 0.281 0.057 DBMET02840 0.187 0.108 DBMET02842 0.184 0.111 DBMET02843 0.192 0.104 DBMET02841 0.187 0.108 DBMET02844 | DBMET02840 | |
| 0.044 | 0.029 | 0.055 | Liver X receptor agonist | 0.055 0.019 DBMET02836 | DBMET02836 | |
| 0.064 | 0.05 | 0.097 | Vanilloid 1 antagonist | 0.066 0.047 DBMET02838 0.097 0.028 DBMET02840 0.062 0.051 DBMET02843 | DBMET02840 | |
| 0.069 | 0.055 | 0.135 | Peroxisome proliferator-activated receptor gamma antagonist | 0.135 0.007 DBMET02836 0.067 0.062 DBMET02838 0.067 0.06 DBMET02840 0.117 0.01 DBMET02842 0.095 0.019 DBMET02843 0.071 0.051 DBMET02844 | DBMET02836 | |
| 0.051 | 0.04 | 0.067 | Acetyl-CoA transferase inhibitor | 0.067 0.026 DBMET02836 0.048 0.046 DBMET02838 | DBMET02836 | |
| 0.025 | 0.014 | 0.034 | Alpha 1a adrenoreceptor agonist | 0.031 0.01 DBMET02838 0.026 0.013 DBMET02839 0.034 0.009 DBMET02840 0.02 0.018 DBMET02842 0.024 0.015 DBMET02843 | DBMET02840 | |
| 0.046 | 0.036 | 0.07 | Mineralocorticoid receptor antagonist | 0.046 0.036 DBMET02838 0.052 0.027 DBMET02839 0.07 0.014 DBMET02840 0.053 0.027 DBMET02842 0.059 0.02 DBMET02843 0.044 0.04 DBMET02841 | DBMET02840 | |
| 0.051 | 0.042 | 0.156 | Leukotriene B4 antagonist | 0.149 0.005 DBMET02836 0.055 0.034 DBMET02839 0.059 0.028 DBMET02840 0.156 0.005 DBMET02842 0.104 0.01 DBMET02843 0.051 0.043 DBMET02841 0.075 0.017 DBMET02844 | DBMET02842 | |
| 0.059 | 0.051 | 0.075 | Nitric oxide donor | 0.068 0.036 DBMET02836 0.063 0.044 DBMET02838 0.064 0.041 DBMET02839 0.075 0.027 DBMET02842 0.07 0.032 DBMET02843 0.066 0.038 DBMET02844 | DBMET02842 | |
| 0.037 | 0.029 | 0.072 | Retinoid X receptor antagonist | 0.072 0.004 DBMET02836 0.05 0.013 DBMET02840 0.069 0.004 DBMET02842 0.052 0.01 DBMET02843 | DBMET02836 | |
| 0.033 | 0.026 | 0.049 | Calcium-independent phospholipase A2 inhibitor | 0.049 0.004 DBMET02836 0.035 0.021 DBMET02838 0.033 0.029 DBMET02839 0.036 0.018 DBMET02842 0.036 0.018 DBMET02843 0.033 0.03 DBMET02844 | DBMET02836 | |
| 0.032 | 0.025 | 0.057 | Liver X receptor beta agonist | 0.057 0.009 DBMET02836 0.036 0.019 DBMET02843 | DBMET02836 | |
| 0.022 | 0.016 | 0.038 | Beta 1 adrenoreceptor agonist | 0.033 0.007 DBMET02836 0.038 0.005 DBMET02838 0.025 0.012 DBMET02839 0.029 0.009 DBMET02840 0.023 0.016 DBMET02842 0.023 0.015 DBMET02843 | DBMET02838 | |
| 0.022 | 0.016 | 0.028 | Elastase 2 inhibitor | 0.023 0.014 DBMET02838 0.02 0.018 DBMET02839 0.028 0.01 DBMET02840 0.027 0.011 DBMET02842 0.021 0.016 DBMET02843 | DBMET02840 | |
| 0.022 | 0.016 | 0.028 | Elastase 2A inhibitor | 0.023 0.014 DBMET02838 0.02 0.018 DBMET02839 0.028 0.01 DBMET02840 0.027 0.011 DBMET02842 0.021 0.016 DBMET02843 | DBMET02840 | |
| 0.033 | 0.027 | 0.062 | Retinoid X alpha receptor antagonist | 0.062 0.004 DBMET02836 0.041 0.013 DBMET02840 0.059 0.004 DBMET02842 0.045 0.009 DBMET02843 | DBMET02836 | |
| 0.085 | 0.08 | 0.139 | Bronchodilator | 0.139 0.035 DBMET02838 0.103 0.061 DBMET02840 0.105 0.058 DBMET02843 0.088 0.077 DBMET02841 | DBMET02838 | |
| 0.028 | 0.025 | 0.061 | Glucocorticoid antagonist | 0.028 0.025 DBMET02838 0.027 0.026 DBMET02839 0.061 0.011 DBMET02840 0.039 0.019 DBMET02842 0.046 0.017 DBMET02843 0.032 0.023 DBMET02841 | DBMET02840 | |
| 0.077 | 0.074 | 0.091 | Alpha adrenoreceptor antagonist | 0.091 0.062 DBMET02838 | DBMET02838 | |
| 0.078 | 0.076 | 0.097 | Vanilloid agonist | 0.079 0.073 DBMET02838 0.081 0.069 DBMET02839 0.097 0.037 DBMET02840 0.082 0.065 DBMET02842 0.091 0.046 DBMET02843 | DBMET02840 | |
| 0.144 | 0.143 | 0.365 | Hypolipemic | 0.365 0.032 DBMET02836 0.203 0.091 DBMET02842 0.189 0.103 DBMET02843 0.157 0.13 DBMET02841 0.228 0.078 DBMET02844 | DBMET02836 | |
| 0.026 | 0.026 | 0.053 | Estrogen-related receptor gamma antagonist | 0.053 0.003 DBMET02836 0.029 0.018 DBMET02843 | DBMET02836 | |
| 0.009 | 0.01 | 0.032 | Beta 3 adrenoreceptor agonist | 0.032 0.004 DBMET02838 0.02 0.005 DBMET02840 0.026 0.004 DBMET02842 0.014 0.006 DBMET02843 | DBMET02838 | |
| 0.156 | 0.159 | 0.266 | Antioxidant | 0.207 0.109 DBMET02836 0.266 0.076 DBMET02840 0.239 0.09 DBMET02842 0.195 0.117 DBMET02843 0.194 0.118 DBMET02841 0.196 0.116 DBMET02844 | DBMET02840 | |
| 0.137 | 0.14 | 0.174 | Death-associated protein kinase 2 inhibitor | 0.172 0.065 DBMET02839 0.174 0.062 DBMET02840 | DBMET02840 | |
| 0.122 | 0.126 | 0.201 | Dual specificity phosphatase 3 inhibitor | 0.201 0.06 DBMET02836 0.197 0.062 DBMET02840 0.162 0.087 DBMET02842 0.129 0.117 DBMET02843 | DBMET02836 | |
| 0.032 | 0.037 | 0.068 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.068 0.005 DBMET02836 | DBMET02836 | |
| 0.039 | 0.044 | 0.042 | Alpha 1L adrenoreceptor agonist | 0.042 0.031 DBMET02840 | DBMET02840 | |
| 0.088 | 0.094 | 0.124 | Folate antagonist | 0.101 0.062 DBMET02836 0.099 0.067 DBMET02838 0.094 0.076 DBMET02839 0.124 0.035 DBMET02842 0.113 0.046 DBMET02843 0.093 0.079 DBMET02844 | DBMET02842 | |
| 0.037 | 0.046 | 0.211 | Peroxisome proliferator-activated receptor alpha agonist | 0.211 0.004 DBMET02836 0.106 0.011 DBMET02842 0.062 0.026 DBMET02843 0.043 0.038 DBMET02844 | DBMET02836 | |
| 0.096 | 0.106 | 0.13 | Interleukin 8 antagonist | 0.13 0.05 DBMET02836 0.1 0.096 DBMET02838 0.105 0.085 DBMET02839 0.116 0.067 DBMET02840 | DBMET02836 | |
| 0.026 | 0.037 | 0.029 | Elastase 2B inhibitor | 0.029 0.026 DBMET02842 | DBMET02842 | |
| 0.026 | 0.037 | 0.029 | Elastase 3A inhibitor | 0.029 0.026 DBMET02842 | DBMET02842 | |
| 0.026 | 0.037 | 0.029 | Elastase 3B inhibitor | 0.029 0.026 DBMET02842 | DBMET02842 | |
| 0.052 | 0.063 | 0.2 | Leukotriene antagonist | 0.156 0.009 DBMET02836 0.071 0.039 DBMET02840 0.2 0.006 DBMET02842 0.123 0.015 DBMET02843 0.099 0.022 DBMET02844 | DBMET02842 | |
| 0.023 | 0.035 | 0.063 | Prostacyclin antagonist | 0.031 0.025 DBMET02840 0.063 0.009 DBMET02842 0.045 0.015 DBMET02843 | DBMET02842 | |
| 0.091 | 0.103 | 0.116 | Nav1.5 sodium channel blocker | 0.116 0.059 DBMET02838 0.101 0.083 DBMET02839 | DBMET02838 | |
| 0.032 | 0.045 | 0.048 | Acetyl-CoA transferase 1 inhibitor | 0.048 0.019 DBMET02836 | DBMET02836 | |
| 0.03 | 0.042 | 0.172 | Urate transporter 1 inhibitor | 0.172 0.004 DBMET02840 0.116 0.005 DBMET02842 0.053 0.017 DBMET02843 0.044 0.022 DBMET02841 | DBMET02840 | |
| 0.1 | 0.112 | 0.337 | Nav1.2 sodium channel blocker | 0.337 0.011 DBMET02836 | DBMET02836 | |
| 0.029 | 0.049 | 0.043 | Delayed rectifier potassium channel blocker | 0.043 0.018 DBMET02836 | DBMET02836 | |
| 0.046 | 0.071 | 0.068 | Acetyl-CoA transferase 2 inhibitor | 0.068 0.019 DBMET02836 | DBMET02836 | |
| 0.1 | 0.125 | 0.117 | Interleukin 1 antagonist | 0.117 0.092 DBMET02836 | DBMET02836 | |
| 0.092 | 0.118 | 0.131 | Estrogen antagonist | 0.12 0.056 DBMET02836 0.131 0.037 DBMET02840 0.101 0.096 DBMET02842 0.102 0.093 DBMET02843 | DBMET02840 | |
| 0.149 | 0.181 | 0.195 | Calpain inhibitor | 0.174 0.142 DBMET02836 0.186 0.128 DBMET02838 0.195 0.118 DBMET02840 | DBMET02840 | |
| 0.079 | 0.111 | 0.659 | Anesthetic local | 0.659 0.003 DBMET02836 | DBMET02836 | |
| 0.019 | 0.052 | 0.074 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.074 0.008 DBMET02840 | DBMET02840 | |
| 0.047 | 0.08 | 0.085 | Leukotriene synthesis inhibitor | 0.085 0.035 DBMET02836 0.069 0.045 DBMET02840 0.084 0.035 DBMET02842 0.065 0.049 DBMET02843 | DBMET02836 | |
| 0.103 | 0.136 | 0.159 | Anticoagulant | 0.121 0.11 DBMET02838 0.148 0.082 DBMET02839 0.151 0.08 DBMET02842 0.159 0.073 DBMET02841 0.118 0.114 DBMET02844 | DBMET02841 | |
| 0.029 | 0.063 | 0.037 | Aggrecanase 1 inhibitor | 0.037 0.032 DBMET02842 | DBMET02842 | |
| 0.163 | 0.199 | 0.35 | Hypoxia-inducible factor 1 alpha inhibitor | 0.35 0.045 DBMET02840 0.203 0.148 DBMET02842 | DBMET02840 | |
| 0.082 | 0.118 | 0.222 | Amylase inhibitor | 0.205 0.043 DBMET02836 0.222 0.037 DBMET02840 0.196 0.046 DBMET02842 0.155 0.062 DBMET02843 0.165 0.057 DBMET02841 | DBMET02840 | |
| 0.029 | 0.066 | 0.075 | Potassium channel Kv1.3 blocker | 0.075 0.014 DBMET02836 | DBMET02836 | |
| 0.063 | 0.101 | 0.074 | Neuropeptide Y antagonist | 0.074 0.07 DBMET02838 | DBMET02838 | |
| 0.082 | 0.12 | 0.143 | Calcium channel (voltage-sensitive) blocker | 0.143 0.037 DBMET02836 | DBMET02836 | |
| 0.017 | 0.056 | 0.076 | Kainate receptor 2 antagonist | 0.076 0.007 DBMET02836 0.031 0.029 DBMET02842 | DBMET02836 | |
| 0.084 | 0.124 | 0.112 | Factor V inhibitor | 0.112 0.048 DBMET02836 0.096 0.079 DBMET02838 | DBMET02836 | |
| 0.016 | 0.058 | 0.176 | Leukotriene A4 hydrolase inhibitor | 0.176 0.004 DBMET02836 | DBMET02836 | |
| 0.125 | 0.168 | 0.358 | Insulin sensitizer | 0.358 0.009 DBMET02836 0.168 0.109 DBMET02838 0.167 0.111 DBMET02839 0.21 0.064 DBMET02842 0.175 0.101 DBMET02843 | DBMET02836 | |
| 0.022 | 0.068 | 0.051 | Dopamine D2 agonist | 0.051 0.026 DBMET02836 | DBMET02836 | |
| 0.049 | 0.095 | 0.123 | Potassium channel (ATP-sensitive) blocker | 0.123 0.008 DBMET02836 | DBMET02836 | |
| 0.022 | 0.068 | 0.072 | Peroxisome proliferator-activated receptor delta antagonist | 0.072 0.007 DBMET02836 0.033 0.023 DBMET02842 0.037 0.017 DBMET02843 | DBMET02836 | |
| 0.184 | 0.231 | 0.444 | 15-Lipoxygenase inhibitor | 0.444 0.056 DBMET02840 0.215 0.197 DBMET02842 | DBMET02840 | |
| 0.012 | 0.059 | 0.05 | Leukotriene B4 receptor 1 antagonist | 0.05 0.007 DBMET02836 0.033 0.016 DBMET02842 0.032 0.016 DBMET02843 0.024 0.023 DBMET02844 | DBMET02836 | |
| 0.11 | 0.158 | 0.196 | Dual specificity phosphatase inhibitor | 0.196 0.057 DBMET02836 0.163 0.081 DBMET02840 0.137 0.11 DBMET02842 | DBMET02836 | |
| 0.022 | 0.071 | 0.043 | Macrophage elastase inhibitor | 0.043 0.03 DBMET02842 | DBMET02842 | |
| 0.014 | 0.064 | 0.032 | Sirtuin 2 inhibitor | 0.032 0.023 DBMET02839 | DBMET02839 | |
| 0.005 | 0.055 | 0.109 | Peroxisome proliferator-activated receptor alpha antagonist | 0.109 0.004 DBMET02836 0.026 0.013 DBMET02842 | DBMET02836 | |
| 0.086 | 0.136 | 0.172 | Lipid peroxidase inhibitor | 0.172 0.054 DBMET02836 0.137 0.077 DBMET02840 0.111 0.103 DBMET02843 | DBMET02836 | |
| 0.052 | 0.105 | 0.106 | Metalloproteinase-2 inhibitor | 0.075 0.058 DBMET02840 0.106 0.035 DBMET02842 | DBMET02842 | |
| 0.037 | 0.092 | 0.066 | Dopamine agonist | 0.066 0.047 DBMET02836 | DBMET02836 | |
| 0.024 | 0.08 | 0.06 | Liver X receptor alpha agonist | 0.06 0.013 DBMET02836 | DBMET02836 | |
| 0.034 | 0.09 | 0.141 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.141 0.005 DBMET02840 0.062 0.027 DBMET02843 | DBMET02840 | |
| 0.08 | 0.139 | 0.212 | Photosensitizer | 0.212 0.01 DBMET02836 0.101 0.087 DBMET02842 | DBMET02836 | |
| 0.022 | 0.081 | 0.045 | Melatonin receptor 1A agonist | 0.045 0.01 DBMET02836 | DBMET02836 | |
| 0.146 | 0.206 | 0.29 | Peptidyltransferase inhibitor | 0.29 0.029 DBMET02836 0.198 0.102 DBMET02838 0.172 0.142 DBMET02839 | DBMET02836 | |
| 0.042 | 0.104 | 0.08 | Potassium channel intermediate-conductance Ca-activated blocker | 0.08 0.018 DBMET02836 | DBMET02836 | |
| 0.06 | 0.125 | 0.293 | Alcohol dehydrogenase inhibitor | 0.293 0.005 DBMET02836 0.117 0.037 DBMET02840 0.119 0.035 DBMET02842 0.103 0.049 DBMET02843 | DBMET02836 | |
| 0.046 | 0.112 | 0.064 | Bcl-xL inhibitor | 0.064 0.029 DBMET02836 | DBMET02836 | |
| 0.004 | 0.072 | 0.013 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.011 DBMET02836 | DBMET02836 | |
| 0.056 | 0.125 | 0.096 | Estrogen receptor alpha antagonist | 0.096 0.03 DBMET02836 0.078 0.053 DBMET02840 | DBMET02836 | |
| 0.03 | 0.099 | 0.068 | Aldosterone antagonist | 0.068 0.015 DBMET02840 0.046 0.035 DBMET02842 0.058 0.021 DBMET02843 | DBMET02840 | |
| 0.043 | 0.113 | 0.093 | Leukotriene C antagonist | 0.093 0.005 DBMET02836 0.078 0.009 DBMET02842 0.059 0.031 DBMET02843 | DBMET02836 | |
| 0.09 | 0.162 | 0.236 | Diuretic | 0.144 0.083 DBMET02836 0.115 0.11 DBMET02839 0.165 0.065 DBMET02840 0.236 0.033 DBMET02842 0.128 0.096 DBMET02843 | DBMET02842 | |
| 0.013 | 0.086 | 0.105 | Peroxisome proliferator-activated receptor delta agonist | 0.105 0.005 DBMET02836 0.036 0.021 DBMET02842 | DBMET02836 | |
| 0.072 | 0.146 | 0.138 | Tubulin antagonist | 0.138 0.065 DBMET02840 0.104 0.097 DBMET02843 | DBMET02840 | |
| 0.028 | 0.102 | 0.067 | Leukotriene C4 antagonist | 0.067 0.005 DBMET02836 0.055 0.008 DBMET02842 0.039 0.027 DBMET02843 | DBMET02836 | |
| 0.17 | 0.248 | 0.286 | Interleukin 2 agonist | 0.274 0.094 DBMET02836 0.201 0.188 DBMET02838 0.261 0.107 DBMET02839 0.229 0.144 DBMET02840 0.253 0.115 DBMET02842 0.231 0.141 DBMET02843 0.286 0.084 DBMET02841 0.243 0.127 DBMET02844 | DBMET02841 | |
| 0.143 | 0.223 | 0.239 | Transcription factor STAT3 inhibitor | 0.237 0.095 DBMET02836 0.192 0.146 DBMET02839 0.239 0.093 DBMET02840 | DBMET02840 | |
| 0.115 | 0.195 | 0.29 | Platelet antagonist | 0.29 0.056 DBMET02836 0.28 0.06 DBMET02842 0.2 0.101 DBMET02841 0.225 0.085 DBMET02844 | DBMET02836 | |
| 0.008 | 0.089 | 0.039 | Squalene synthetase inhibitor | 0.039 0.019 DBMET02836 | DBMET02836 | |
| 0.004 | 0.087 | 0.023 | Ileal bile acid transport inhibitor | 0.023 0.007 DBMET02836 | DBMET02836 | |
| 0.033 | 0.117 | 0.048 | Autotaxin inhibitor | 0.048 0.044 DBMET02836 | DBMET02836 | |
| 0.024 | 0.107 | 0.053 | Alpha tubulin antagonist | 0.053 0.037 DBMET02840 | DBMET02840 | |
| 0.033 | 0.116 | 0.06 | Collagenase 3 inhibitor | 0.06 0.041 DBMET02836 0.056 0.047 DBMET02842 | DBMET02836 | |
| 0.068 | 0.152 | 0.102 | Nav1.4 sodium channel blocker | 0.102 0.073 DBMET02839 | DBMET02839 | |
| 0.043 | 0.127 | 0.298 | Calcium antagonist | 0.298 0.005 DBMET02836 | DBMET02836 | |
| 0.062 | 0.147 | 0.118 | Estrogen receptor beta antagonist | 0.09 0.083 DBMET02836 0.118 0.034 DBMET02840 | DBMET02840 | |
| 0.013 | 0.1 | 0.027 | Thyroid hormone agonist | 0.024 0.022 DBMET02840 0.027 0.016 DBMET02842 | DBMET02842 | |
| 0.072 | 0.162 | 0.171 | Acetylcholinesterase inhibitor | 0.171 0.044 DBMET02836 | DBMET02836 | |
| 0.009 | 0.103 | 0.069 | Progesterone antagonist | 0.069 0.013 DBMET02840 | DBMET02840 | |
| 0.091 | 0.187 | 0.152 | Vanilloid 1 agonist | 0.152 0.036 DBMET02836 0.122 0.083 DBMET02840 0.112 0.108 DBMET02842 0.123 0.079 DBMET02843 | DBMET02836 | |
| 0.012 | 0.113 | 0.029 | Liver X receptor antagonist | 0.029 0.025 DBMET02836 | DBMET02836 | |
| 0.007 | 0.108 | 0.021 | Vitamin D receptor agonist | 0.021 0.006 DBMET02836 | DBMET02836 | |
| 0.009 | 0.111 | 0.033 | Leukotriene B4 receptor 2 antagonist | 0.033 0.007 DBMET02836 | DBMET02836 | |
| 0.012 | 0.115 | 0.032 | Liver X receptor alpha antagonist | 0.032 0.016 DBMET02836 | DBMET02836 | |
| 0.008 | 0.112 | 0.023 | Leukotriene D4 antagonist | 0.023 0.022 DBMET02842 | DBMET02842 | |
| 0.012 | 0.121 | 0.028 | Lysophosphatidic acid receptor 1 agonist | 0.028 0.013 DBMET02836 | DBMET02836 | |
| 0.147 | 0.26 | 0.36 | Insulysin inhibitor | 0.36 0.031 DBMET02836 | DBMET02836 | |
| 0.029 | 0.143 | 0.075 | Lipase inhibitor | 0.075 0.048 DBMET02836 | DBMET02836 | |
| 0.062 | 0.178 | 0.224 | Nav1.6 sodium channel blocker | 0.224 0.013 DBMET02836 | DBMET02836 | |
| 0.042 | 0.161 | 0.139 | Butyrylcholinesterase inhibitor | 0.139 0.038 DBMET02836 | DBMET02836 | |
| 0.021 | 0.14 | 0.083 | Neuraminidase (Influenza A) inhibitor | 0.083 0.005 DBMET02836 0.043 0.037 DBMET02844 | DBMET02836 | |
| 0.057 | 0.181 | 0.272 | Nav1.3 sodium channel blocker | 0.272 0.011 DBMET02836 | DBMET02836 | |
| 0.06 | 0.189 | 0.267 | Carbonic anhydrase XV inhibitor | 0.267 0.01 DBMET02836 0.097 0.071 DBMET02839 0.092 0.079 DBMET02840 | DBMET02836 | |
| 0.085 | 0.215 | 0.319 | DNA methyltransferase I inhibitor | 0.319 0.02 DBMET02836 | DBMET02836 | |
| 0.081 | 0.212 | 0.178 | Farnesoid X receptor antagonist | 0.178 0.03 DBMET02836 0.119 0.107 DBMET02842 0.13 0.083 DBMET02843 | DBMET02836 | |
| 0.047 | 0.178 | 0.178 | Prolactin inhibitor | 0.178 0.013 DBMET02836 | DBMET02836 | |
| 0.057 | 0.188 | 0.159 | AMP-activated protein kinase stimulant | 0.115 0.054 DBMET02836 0.131 0.041 DBMET02840 0.098 0.073 DBMET02842 0.112 0.056 DBMET02843 0.159 0.023 DBMET02841 0.098 0.073 DBMET02844 | DBMET02841 | |
| 0.073 | 0.206 | 0.156 | Cholinergic | 0.156 0.072 DBMET02836 | DBMET02836 | |
| 0.011 | 0.147 | 0.102 | Estradiol 17 beta-dehydrogenase inhibitor | 0.102 0.01 DBMET02840 | DBMET02840 | |
| 0.094 | 0.23 | 0.215 | Platelet aggregation inhibitor | 0.215 0.071 DBMET02836 0.148 0.131 DBMET02842 | DBMET02836 | |
| 0.193 | 0.331 | 0.628 | Caspase 9 stimulant | 0.628 0.033 DBMET02836 | DBMET02836 | |
| 0.083 | 0.221 | 0.145 | Platelet adhesion inhibitor | 0.136 0.123 DBMET02842 0.145 0.111 DBMET02844 | DBMET02844 | |
| 0.027 | 0.167 | 0.2 | Squalene epoxidase inhibitor | 0.2 0.002 DBMET02836 | DBMET02836 | |
| 0.011 | 0.152 | 0.035 | Retinoid X gamma receptor antagonist | 0.035 0.007 DBMET02836 | DBMET02836 | |
| 0.041 | 0.184 | 0.084 | 5-Lipoxygenase inhibitor | 0.084 0.076 DBMET02840 0.082 0.079 DBMET02842 | DBMET02840 | |
| 0.176 | 0.321 | 0.361 | Calcium channel L-type activator | 0.335 0.129 DBMET02836 0.361 0.109 DBMET02840 0.235 0.222 DBMET02842 0.231 0.228 DBMET02843 0.24 0.217 DBMET02841 | DBMET02840 | |
| 0.052 | 0.199 | 0.17 | DNA polymerase I inhibitor | 0.17 0.039 DBMET02836 0.094 0.093 DBMET02842 0.109 0.077 DBMET02841 0.139 0.055 DBMET02844 | DBMET02836 | |
| 0.042 | 0.189 | 0.134 | Antihistaminic | 0.134 0.037 DBMET02836 | DBMET02836 | |
| 0.147 | 0.294 | 0.736 | Histamine release inhibitor | 0.736 0.004 DBMET02836 0.226 0.175 DBMET02842 | DBMET02836 | |
| 0.014 | 0.163 | 0.065 | Aromatase inhibitor | 0.065 0.038 DBMET02840 | DBMET02840 | |
| 0.01 | 0.159 | 0.032 | Calcium-sensing receptor agonist | 0.032 0.011 DBMET02836 | DBMET02836 | |
| 0.032 | 0.181 | 0.114 | Androgen antagonist | 0.114 0.036 DBMET02840 | DBMET02840 | |
| 0.008 | 0.158 | 0.106 | Retinoid X receptor agonist | 0.106 0.004 DBMET02836 | DBMET02836 | |
| 0.004 | 0.16 | 0.037 | Prostaglandin H2 antagonist | 0.037 0.007 DBMET02836 | DBMET02836 | |
| 0.033 | 0.189 | 0.113 | Histamine antagonist | 0.113 0.041 DBMET02836 | DBMET02836 | |
| 0.008 | 0.166 | 0.044 | Retinoic acid beta receptor agonist | 0.044 0.004 DBMET02836 | DBMET02836 | |
| 0.006 | 0.17 | 0.038 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.038 0.009 DBMET02840 | DBMET02840 | |
| 0.072 | 0.236 | 0.184 | Sphingosine 1-phosphate receptor 4 antagonist | 0.184 0.013 DBMET02836 | DBMET02836 | |
| 0.049 | 0.214 | 0.082 | Thioredoxin inhibitor | 0.082 0.078 DBMET02836 | DBMET02836 | |
| 0.011 | 0.175 | 0.024 | Acid ceramidase inhibitor | 0.024 0.021 DBMET02836 | DBMET02836 | |
| 0.006 | 0.171 | 0.04 | Retinoid X gamma receptor agonist | 0.04 0.007 DBMET02836 | DBMET02836 | |
| 0.004 | 0.172 | 0.057 | Dopamine autoreceptor agonist | 0.057 0.006 DBMET02836 | DBMET02836 | |
| 0.031 | 0.203 | 0.1 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.1 0.01 DBMET02840 | DBMET02840 | |
| 0.027 | 0.2 | 0.06 | Sphingosine 1-phosphate receptor 1 antagonist | 0.058 0.032 DBMET02836 0.06 0.03 DBMET02842 | DBMET02842 | |
| 0.134 | 0.308 | 0.167 | 5 Hydroxytryptamine 3E antagonist | 0.167 0.145 DBMET02836 | DBMET02836 | |
| 0.008 | 0.183 | 0.069 | Liver X receptor beta antagonist | 0.069 0.005 DBMET02836 | DBMET02836 | |
| 0.06 | 0.238 | 0.251 | Angiogenesis stimulant | 0.251 0.07 DBMET02836 0.148 0.124 DBMET02844 | DBMET02836 | |
| 0.038 | 0.225 | 0.085 | Sphingosine 1-phosphate receptor antagonist | 0.082 0.043 DBMET02836 0.085 0.036 DBMET02842 | DBMET02842 | |
| 0.028 | 0.216 | 0.102 | Epoxide hydrolase inhibitor | 0.102 0.024 DBMET02836 | DBMET02836 | |
| 0.075 | 0.263 | 0.165 | Hepatoprotectant | 0.165 0.094 DBMET02836 0.135 0.127 DBMET02841 0.138 0.123 DBMET02844 | DBMET02836 | |
| 0.004 | 0.199 | 0.059 | Prostaglandin EP2 agonist | 0.059 0.005 DBMET02836 | DBMET02836 | |
| 0.009 | 0.205 | 0.024 | Toll-Like receptor 8 agonist | 0.024 0.008 DBMET02836 | DBMET02836 | |
| 0.038 | 0.233 | 0.106 | Topoisomerase II inhibitor | 0.106 0.08 DBMET02836 | DBMET02836 | |
| 0.022 | 0.219 | 0.079 | Thromboxane synthase inhibitor | 0.079 0.012 DBMET02836 0.052 0.042 DBMET02842 | DBMET02836 | |
| 0.012 | 0.217 | 0.021 | Vitamin D receptor antagonist | 0.021 0.018 DBMET02836 | DBMET02836 | |
| 0.005 | 0.21 | 0.042 | Sphingosine 1-phosphate receptor 3 agonist | 0.042 0.02 DBMET02836 | DBMET02836 | |
| 0.007 | 0.214 | 0.056 | Lysophosphatidic acid 1 receptor antagonist | 0.056 0.004 DBMET02836 | DBMET02836 | |
| 0.058 | 0.266 | 0.166 | Interleukin 4 antagonist | 0.166 0.037 DBMET02836 0.128 0.074 DBMET02841 | DBMET02836 | |
| 0.046 | 0.255 | 0.253 | Electrolyte absorption antagonist | 0.253 0.005 DBMET02836 | DBMET02836 | |
| 0.069 | 0.279 | 0.181 | Interleukin antagonist | 0.181 0.096 DBMET02836 | DBMET02836 | |
| 0.031 | 0.243 | 0.233 | Ornithine decarboxylase inhibitor | 0.233 0.004 DBMET02836 | DBMET02836 | |
| 0.039 | 0.253 | 0.234 | Chelator | 0.234 0.019 DBMET02836 | DBMET02836 | |
| 0.02 | 0.236 | 0.067 | Acetylcholine M4 receptor antagonist | 0.067 0.061 DBMET02836 | DBMET02836 | |
| 0.096 | 0.315 | 0.297 | Transcription factor NF kappa B inhibitor | 0.297 0.096 DBMET02836 0.269 0.114 DBMET02840 0.189 0.181 DBMET02841 | DBMET02836 | |
| 0.051 | 0.271 | 0.145 | Mcl-1 antagonist | 0.145 0.095 DBMET02836 | DBMET02836 | |
| 0.069 | 0.29 | 0.303 | DNA methylase inhibitor | 0.303 0.027 DBMET02836 | DBMET02836 | |
| 0.071 | 0.293 | 0.134 | Growth hormone agonist | 0.134 0.102 DBMET02839 | DBMET02839 | |
| 0.013 | 0.236 | 0.064 | Carbonic anhydrase XIV inhibitor | 0.064 0.022 DBMET02836 | DBMET02836 | |
| 0.038 | 0.267 | 0.183 | Glutathione S-transferase inhibitor | 0.183 0.007 DBMET02836 | DBMET02836 | |
| 0.026 | 0.257 | 0.069 | CD45 antagonist | 0.069 0.016 DBMET02836 | DBMET02836 | |
| 0.01 | 0.242 | 0.046 | Angiotensin II receptor antagonist | 0.046 0.009 DBMET02836 | DBMET02836 | |
| 0.05 | 0.283 | 0.24 | Amyloid beta aggregation inhibitor | 0.24 0.061 DBMET02836 | DBMET02836 | |
| 0.04 | 0.273 | 0.157 | Xanthine oxidase inhibitor | 0.157 0.032 DBMET02836 0.091 0.069 DBMET02840 | DBMET02836 | |
| 0.097 | 0.333 | 0.286 | Alpha-glucosidase inhibitor | 0.286 0.167 DBMET02840 | DBMET02840 | |
| 0.009 | 0.245 | 0.099 | Prostaglandin EP2 antagonist | 0.099 0.019 DBMET02836 | DBMET02836 | |
| 0.019 | 0.256 | 0.129 | Neuraminidase (influenza) inhibitor | 0.129 0.01 DBMET02836 | DBMET02836 | |
| 0.011 | 0.25 | 0.035 | Benzodiazepine receptor peripheral-type antagonist | 0.035 0.021 DBMET02836 | DBMET02836 | |
| 0.007 | 0.245 | 0.124 | Oleamide hydrolase inhibitor | 0.124 0.006 DBMET02836 | DBMET02836 | |
| 0.034 | 0.274 | 0.1 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.1 0.039 DBMET02836 | DBMET02836 | |
| 0.074 | 0.314 | 0.177 | Streptokinase A inhibitor | 0.177 0.148 DBMET02840 | DBMET02840 | |
| 0.007 | 0.249 | 0.027 | Prostaglandin F2 alpha agonist | 0.027 0.011 DBMET02836 | DBMET02836 | |
| 0.098 | 0.34 | 0.362 | Immunosuppressant | 0.362 0.081 DBMET02836 0.203 0.195 DBMET02841 0.262 0.139 DBMET02844 | DBMET02836 | |
| 0.005 | 0.247 | 0.059 | Kainate receptor antagonist | 0.059 0.017 DBMET02836 | DBMET02836 | |
| 0.102 | 0.346 | 0.248 | Neuropeptide Y2 antagonist | 0.248 0.058 DBMET02836 | DBMET02836 | |
| 0.008 | 0.253 | 0.058 | Carbonic anhydrase VB inhibitor | 0.058 0.037 DBMET02836 | DBMET02836 | |
| 0.016 | 0.261 | 0.063 | Cholesterol esterase inhibitor | 0.063 0.014 DBMET02836 | DBMET02836 | |
| 0.012 | 0.258 | 0.121 | Neuraminidase inhibitor | 0.121 0.01 DBMET02836 | DBMET02836 | |
| 0.138 | 0.384 | 0.301 | Apoptosis agonist | 0.301 0.172 DBMET02836 | DBMET02836 | |
| 0.031 | 0.28 | 0.1 | Carbonic anhydrase VI inhibitor | 0.1 0.039 DBMET02836 0.074 0.066 DBMET02840 | DBMET02836 | |
| 0.014 | 0.263 | 0.12 | Lysophosphatidic acid 3 receptor antagonist | 0.12 0.004 DBMET02836 | DBMET02836 | |
| 0.01 | 0.261 | 0.066 | Acetylcholine M3 receptor antagonist | 0.066 0.035 DBMET02836 | DBMET02836 | |
| 0.027 | 0.279 | 0.175 | Histamine N-methyltransferase inhibitor | 0.175 0.008 DBMET02836 | DBMET02836 | |
| 0.011 | 0.264 | 0.09 | Sphingosine 1-phosphate receptor agonist | 0.09 0.007 DBMET02836 | DBMET02836 | |
| 0.008 | 0.261 | 0.056 | Angiotensin AT1 receptor antagonist | 0.056 0.01 DBMET02836 | DBMET02836 | |
| 0.007 | 0.26 | 0.039 | Retinoid X beta receptor antagonist | 0.039 0.003 DBMET02836 | DBMET02836 | |
| 0.006 | 0.261 | 0.031 | Prostaglandin D2 agonist | 0.031 0.021 DBMET02836 | DBMET02836 | |
| 0.011 | 0.267 | 0.051 | 5 Hydroxytryptamine 4 antagonist | 0.051 0.036 DBMET02836 | DBMET02836 | |
| 0.055 | 0.315 | 0.148 | Amyloid beta precursor protein antagonist | 0.148 0.104 DBMET02836 | DBMET02836 | |
| 0.004 | 0.267 | 0.029 | Retinoic acid alpha receptor antagonist | 0.029 0.007 DBMET02836 | DBMET02836 | |
| 0.005 | 0.272 | 0.099 | Geranyltranstransferase inhibitor | 0.099 0.004 DBMET02836 | DBMET02836 | |
| 0.006 | 0.274 | 0.045 | Retinoic acid receptor agonist | 0.045 0.006 DBMET02836 | DBMET02836 | |
| 0.005 | 0.275 | 0.03 | HCV NS5B polymerase inhibitor | 0.03 0.024 DBMET02840 | DBMET02840 | |
| 0.039 | 0.312 | 0.209 | Carbonic anhydrase III inhibitor | 0.209 0.015 DBMET02836 | DBMET02836 | |
| 0.029 | 0.304 | 0.083 | Adenine nucleotide translocase inhibitor | 0.083 0.008 DBMET02836 | DBMET02836 | |
| 0.014 | 0.29 | 0.089 | Amidase inhibitor | 0.089 0.031 DBMET02836 | DBMET02836 | |
| 0.005 | 0.281 | 0.027 | Carnitine palmitoyltransferase 1A inhibitor | 0.027 0.022 DBMET02836 | DBMET02836 | |
| 0.005 | 0.284 | 0.029 | Estrogen-related receptor gamma agonist | 0.029 0.004 DBMET02836 | DBMET02836 | |
| 0.004 | 0.284 | 0.035 | Retinoid X beta receptor agonist | 0.035 0.007 DBMET02836 | DBMET02836 | |
| 0.021 | 0.302 | 0.115 | MAO inhibitor | 0.115 0.078 DBMET02836 | DBMET02836 | |
| 0.016 | 0.299 | 0.066 | CDC25B inhibitor | 0.066 0.042 DBMET02836 | DBMET02836 | |
| 0.03 | 0.314 | 0.207 | Sphingomyelinase inhibitor | 0.207 0.008 DBMET02836 | DBMET02836 | |
| 0.016 | 0.302 | 0.097 | NMDA receptor antagonist | 0.097 0.049 DBMET02836 | DBMET02836 | |
| 0.054 | 0.34 | 0.152 | Thiol protease inhibitor | 0.152 0.067 DBMET02836 | DBMET02836 | |
| 0.076 | 0.365 | 0.281 | Lipocortins synthesis antagonist | 0.281 0.025 DBMET02836 | DBMET02836 | |
| 0.004 | 0.294 | 0.028 | Retinoic acid receptor antagonist | 0.028 0.006 DBMET02836 | DBMET02836 | |
| 0.004 | 0.296 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.016 DBMET02836 | DBMET02836 | |
| 0.007 | 0.299 | 0.031 | Retinoic acid gamma receptor agonist | 0.031 0.006 DBMET02836 | DBMET02836 | |
| 0.076 | 0.371 | 0.291 | 12-Lipoxygenase inhibitor | 0.291 0.085 DBMET02840 | DBMET02840 | |
| 0.027 | 0.323 | 0.08 | ATPase (Vacuolar H+) inhibitor | 0.08 0.079 DBMET02836 | DBMET02836 | |
| 0.014 | 0.311 | 0.146 | Histamine H1 receptor antagonist | 0.146 0.025 DBMET02836 | DBMET02836 | |
| 0.12 | 0.418 | 0.262 | Ca(v)3.3 blocker | 0.262 0.083 DBMET02836 | DBMET02836 | |
| 0.005 | 0.307 | 0.074 | Sphingosine 1-phosphate receptor 1 agonist | 0.074 0.007 DBMET02836 | DBMET02836 | |
| 0.014 | 0.319 | 0.169 | Monophenol monooxygenase inhibitor | 0.169 0.04 DBMET02836 | DBMET02836 | |
| 0.044 | 0.349 | 0.087 | Toll-Like receptor 3 antagonist | 0.087 0.076 DBMET02836 | DBMET02836 | |
| 0.013 | 0.319 | 0.047 | H+/K+-transporting ATPase inhibitor | 0.047 0.041 DBMET02836 | DBMET02836 | |
| 0.006 | 0.313 | 0.121 | Retinoid X alpha receptor agonist | 0.121 0.004 DBMET02836 | DBMET02836 | |
| 0.106 | 0.412 | 0.19 | Caspase 3 stimulant | 0.19 0.184 DBMET02836 | DBMET02836 | |
| 0.042 | 0.351 | 0.12 | NADPH oxidase inhibitor | 0.12 0.083 DBMET02836 | DBMET02836 | |
| 0.01 | 0.321 | 0.067 | Retinoic acid alpha receptor agonist | 0.067 0.007 DBMET02836 | DBMET02836 | |
| 0.004 | 0.316 | 0.05 | Free fatty acid receptor 1 antagonist | 0.05 0.009 DBMET02836 | DBMET02836 | |
| 0.046 | 0.361 | 0.328 | Adenylate kinase inhibitor | 0.328 0.005 DBMET02836 | DBMET02836 | |
| 0.026 | 0.347 | 0.243 | Gastric antisecretory | 0.243 0.007 DBMET02836 | DBMET02836 | |
| 0.019 | 0.34 | 0.077 | Prostaglandin F2 alpha antagonist | 0.077 0.025 DBMET02836 | DBMET02836 | |
| 0.019 | 0.341 | 0.109 | Carbonic anhydrase XIII inhibitor | 0.109 0.034 DBMET02836 | DBMET02836 | |
| 0.131 | 0.454 | 0.483 | Antiinflammatory | 0.293 0.222 DBMET02840 0.276 0.238 DBMET02842 0.259 0.257 DBMET02843 0.483 0.095 DBMET02841 0.36 0.165 DBMET02844 | DBMET02841 | |
| 0.044 | 0.368 | 0.218 | Arachidonic acid antagonist | 0.218 0.018 DBMET02836 | DBMET02836 | |
| 0.008 | 0.334 | 0.055 | Acetylcholine M2 receptor antagonist | 0.055 0.049 DBMET02836 | DBMET02836 | |
| 0.025 | 0.357 | 0.08 | Ryanodine receptor antagonist | 0.08 0.009 DBMET02836 | DBMET02836 | |
| 0.042 | 0.383 | 0.358 | Immunostimulant | 0.358 0.062 DBMET02836 | DBMET02836 | |
| 0.004 | 0.35 | 0.057 | Carnitine palmitoyltransferase inhibitor | 0.057 0.005 DBMET02836 | DBMET02836 | |
| 0.007 | 0.356 | 0.107 | MAO B inhibitor | 0.107 0.057 DBMET02836 | DBMET02836 | |
| 0.005 | 0.354 | 0.054 | Carnitine palmitoyltransferase 1 inhibitor | 0.054 0.006 DBMET02836 | DBMET02836 | |
| 0.046 | 0.395 | 0.354 | Antiamyloidogenic | 0.354 0.038 DBMET02836 | DBMET02836 | |
| 0.009 | 0.361 | 0.151 | Xanthine dehydrogenase inhibitor | 0.151 0.007 DBMET02836 | DBMET02836 | |
| 0.003 | 0.359 | 0.014 | Retinoic acid receptor gamma antagonist | 0.014 0.006 DBMET02836 | DBMET02836 | |
| 0.016 | 0.373 | 0.092 | NMDA receptor agonist | 0.092 0.023 DBMET02836 | DBMET02836 | |
| 0.119 | 0.479 | 0.668 | 5 Hydroxytryptamine release inhibitor | 0.668 0.005 DBMET02836 | DBMET02836 | |
| 0.002 | 0.364 | 0.039 | Prostaglandin E2 agonist | 0.039 0.007 DBMET02836 | DBMET02836 | |
| 0.015 | 0.381 | 0.088 | Epithelial sodium channel blocker | 0.088 0.01 DBMET02836 | DBMET02836 | |
| 0.034 | 0.401 | 0.202 | Acetylcholine M1 receptor antagonist | 0.202 0.041 DBMET02836 | DBMET02836 | |
| 0.034 | 0.403 | 0.127 | Lanosterol 14 alpha demethylase inhibitor | 0.127 0.024 DBMET02836 | DBMET02836 | |
| 0.077 | 0.446 | 0.694 | Vasodilator, peripheral | 0.694 0.007 DBMET02836 | DBMET02836 | |
| 0.058 | 0.428 | 0.187 | ATPase inhibitor | 0.187 0.05 DBMET02836 | DBMET02836 | |
| 0.057 | 0.43 | 0.139 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.139 0.095 DBMET02836 | DBMET02836 | |
| 0.033 | 0.407 | 0.133 | Adenylate cyclase inhibitor | 0.133 0.057 DBMET02836 | DBMET02836 | |
| 0.019 | 0.393 | 0.192 | Alkylator | 0.192 0.029 DBMET02836 | DBMET02836 | |
| 0.034 | 0.409 | 0.11 | Toll-Like receptor 4 antagonist | 0.11 0.055 DBMET02836 | DBMET02836 | |
| 0 | 0.378 | 0.008 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.007 DBMET02836 | DBMET02836 | |
| 0.063 | 0.442 | 0.185 | Transcription factor STAT inhibitor | 0.185 0.159 DBMET02836 0.176 0.175 DBMET02840 | DBMET02836 | |
| 0.003 | 0.384 | 0.059 | Prostaglandin agonist | 0.059 0.008 DBMET02836 | DBMET02836 | |
| 0.006 | 0.387 | 0.036 | Vanilloid 2 agonist | 0.036 0.005 DBMET02836 | DBMET02836 | |
| 0.018 | 0.4 | 0.203 | Interferon agonist | 0.203 0.006 DBMET02836 | DBMET02836 | |
| 0.007 | 0.392 | 0.039 | Oxytocin agonist | 0.039 0.033 DBMET02836 | DBMET02836 | |
| 0.025 | 0.412 | 0.144 | Caspase 3 inhibitor | 0.144 0.033 DBMET02836 | DBMET02836 | |
| 0.025 | 0.419 | 0.075 | Phosphodiesterase VI inhibitor | 0.075 0.051 DBMET02836 | DBMET02836 | |
| 0.036 | 0.433 | 0.317 | Cyclooxygenase 3 inhibitor | 0.317 0.005 DBMET02836 | DBMET02836 | |
| 0.061 | 0.46 | 0.248 | Sphingosine 1-phosphate receptor 5 antagonist | 0.248 0.004 DBMET02836 | DBMET02836 | |
| 0.012 | 0.412 | 0.064 | Sphingosine 1-phosphate receptor 5 agonist | 0.064 0.021 DBMET02836 | DBMET02836 | |
| 0.015 | 0.417 | 0.074 | Glutamate (mGluR4) antagonist | 0.074 0.009 DBMET02836 | DBMET02836 | |
| 0.083 | 0.487 | 0.386 | Calcium channel activator | 0.386 0.03 DBMET02836 | DBMET02836 | |
| 0.073 | 0.477 | 0.302 | 5 Hydroxytryptamine release stimulant | 0.302 0.069 DBMET02836 | DBMET02836 | |
| 0.041 | 0.448 | 0.22 | Sphingosine 1-phosphate receptor 2 antagonist | 0.22 0.005 DBMET02836 | DBMET02836 | |
| 0.01 | 0.419 | 0.063 | Plasmepsin II inhibitor | 0.063 0.01 DBMET02836 | DBMET02836 | |
| 0.002 | 0.411 | 0.014 | Retinoic acid beta receptor antagonist | 0.014 0.006 DBMET02836 | DBMET02836 | |
| 0.041 | 0.452 | 0.175 | Hemostatic | 0.175 0.045 DBMET02836 | DBMET02836 | |
| 0.042 | 0.458 | 0.166 | Insulin secretagoues | 0.166 0.059 DBMET02836 | DBMET02836 | |
| 0.014 | 0.431 | 0.044 | Carnitine palmitoyltransferase 1B inhibitor | 0.044 0.041 DBMET02836 | DBMET02836 | |
| 0.021 | 0.438 | 0.151 | Acetylcholine muscarinic antagonist | 0.151 0.043 DBMET02836 | DBMET02836 | |
| 0.004 | 0.423 | 0.048 | Prostaglandin EP4 antagonist | 0.048 0.009 DBMET02836 | DBMET02836 | |
| 0.005 | 0.426 | 0.067 | Prostaglandin E2 antagonist | 0.067 0.025 DBMET02836 | DBMET02836 | |
| 0.06 | 0.483 | 0.738 | Cholesterol antagonist | 0.738 0.006 DBMET02836 | DBMET02836 | |
| 0.008 | 0.436 | 0.048 | Prolyl endopeptidase inhibitor | 0.048 0.039 DBMET02836 | DBMET02836 | |
| 0.015 | 0.445 | 0.072 | Heparanase inhibitor | 0.072 0.01 DBMET02836 | DBMET02836 | |
| 0.031 | 0.467 | 0.112 | Interleukin 5 antagonist | 0.112 0.03 DBMET02836 | DBMET02836 | |
| 0.021 | 0.464 | 0.145 | Neurotrophic factor | 0.145 0.064 DBMET02836 | DBMET02836 | |
| 0.02 | 0.464 | 0.211 | Aminopeptidase B inhibitor | 0.211 0.019 DBMET02836 | DBMET02836 | |
| 0.059 | 0.504 | 0.321 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.321 0.018 DBMET02836 | DBMET02836 | |
| 0.019 | 0.464 | 0.546 | Anesthetic general | 0.546 0.005 DBMET02836 | DBMET02836 | |
| 0.017 | 0.462 | 0.059 | Glucosylceramidase inhibitor | 0.059 0.032 DBMET02836 | DBMET02836 | |
| 0.059 | 0.506 | 0.304 | Gastrin inhibitor | 0.304 0.03 DBMET02836 | DBMET02836 | |
| 0.002 | 0.449 | 0.053 | Arginase inhibitor | 0.053 0.013 DBMET02836 | DBMET02836 | |
| 0.011 | 0.462 | 0.116 | Sphingosine 1-phosphate receptor 3 antagonist | 0.116 0.005 DBMET02836 | DBMET02836 | |
| 0.017 | 0.469 | 0.124 | Interferon inducer | 0.124 0.007 DBMET02836 | DBMET02836 | |
| 0.025 | 0.482 | 0.187 | Antibacterial (Helicobacter pylori) | 0.187 0.026 DBMET02836 | DBMET02836 | |
| 0.02 | 0.483 | 0.089 | Phosphodiesterase 1C inhibitor | 0.089 0.014 DBMET02836 | DBMET02836 | |
| 0.045 | 0.51 | 0.338 | Sigma receptor agonist | 0.338 0.032 DBMET02836 | DBMET02836 | |
| 0.041 | 0.507 | 0.305 | DNA damaging | 0.305 0.055 DBMET02836 | DBMET02836 | |
| 0.007 | 0.477 | 0.045 | AMPA 4 receptor antagonist | 0.045 0.019 DBMET02836 | DBMET02836 | |
| 0.031 | 0.502 | 0.127 | Phosphodiesterase 6D inhibitor | 0.127 0.02 DBMET02836 | DBMET02836 | |
| 0.003 | 0.476 | 0.019 | Kainate receptor 5 antagonist | 0.019 0.016 DBMET02836 | DBMET02836 | |
| 0.015 | 0.488 | 0.124 | Macrophage migration inhibitory factor inhibitor | 0.124 0.024 DBMET02836 | DBMET02836 | |
| 0.094 | 0.571 | 0.429 | 5 Hydroxytryptamine uptake stimulant | 0.429 0.01 DBMET02836 | DBMET02836 | |
| 0.018 | 0.495 | 0.059 | Phosphodiesterase 1B inhibitor | 0.059 0.043 DBMET02836 | DBMET02836 | |
| 0.009 | 0.494 | 0.147 | Sphingosine 1-phosphate receptor 4 agonist | 0.147 0.009 DBMET02836 | DBMET02836 | |
| 0.048 | 0.534 | 0.632 | Superoxide dismutase inhibitor | 0.632 0.005 DBMET02836 | DBMET02836 | |
| 0.008 | 0.497 | 0.058 | Sphingosine kinase inhibitor | 0.058 0.043 DBMET02836 | DBMET02836 | |
| 0.023 | 0.512 | 0.215 | Toll-Like receptor 2 antagonist | 0.215 0.018 DBMET02836 | DBMET02836 | |
| 0.008 | 0.498 | 0.055 | Potassium channel (Inward rectifier) blocker | 0.055 0.028 DBMET02836 | DBMET02836 | |
| 0.004 | 0.498 | 0.053 | NMDA receptor subunit 3B antagonist | 0.053 0.023 DBMET02836 | DBMET02836 | |
| 0.04 | 0.538 | 0.219 | Interferon gamma antagonist | 0.219 0.035 DBMET02836 | DBMET02836 | |
| 0.007 | 0.506 | 0.188 | Catalase inhibitor | 0.188 0.018 DBMET02836 | DBMET02836 | |
| 0.019 | 0.519 | 0.07 | Potassium channel large-conductance Ca-activated activator | 0.07 0.045 DBMET02836 | DBMET02836 | |
| 0.034 | 0.535 | 0.119 | Estrogen-related receptor beta agonist | 0.119 0.01 DBMET02836 | DBMET02836 | |
| 0.001 | 0.509 | 0.022 | Carbonic anhydrase X inhibitor | 0.022 0.007 DBMET02836 | DBMET02836 | |
| 0.001 | 0.509 | 0.022 | Carbonic anhydrase VIII inhibitor | 0.022 0.007 DBMET02836 | DBMET02836 | |
| 0.022 | 0.531 | 0.246 | Triose-phosphate isomerase inhibitor | 0.246 0.007 DBMET02836 | DBMET02836 | |
| 0.006 | 0.517 | 0.076 | Na+ K+ transporting ATPase inhibitor | 0.076 0.054 DBMET02836 | DBMET02836 | |
| 0.015 | 0.527 | 0.132 | Protein kinase C gamma inhibitor | 0.132 0.044 DBMET02836 | DBMET02836 | |
| 0.074 | 0.587 | 0.304 | Tyrosine 3 hydroxylase inhibitor | 0.304 0.031 DBMET02836 | DBMET02836 | |
| 0.006 | 0.528 | 0.083 | Selectin antagonist | 0.071 0.042 DBMET02836 0.083 0.035 DBMET02841 | DBMET02841 | |
| 0.003 | 0.527 | 0.119 | Ornithine carbamoyltransferase inhibitor | 0.119 0.013 DBMET02836 | DBMET02836 | |
| 0.035 | 0.559 | 0.367 | Cyclic AMP phosphodiesterase inhibitor | 0.367 0.022 DBMET02836 | DBMET02836 | |
| 0.001 | 0.527 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 DBMET02841 | DBMET02841 | |
| 0.008 | 0.535 | 0.132 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.132 0.025 DBMET02836 | DBMET02836 | |
| 0.039 | 0.566 | 0.137 | DNA repair enzyme inhibitor | 0.137 0.046 DBMET02836 | DBMET02836 | |
| 0.032 | 0.566 | 0.159 | Adenylate cyclase stimulant | 0.159 0.048 DBMET02836 | DBMET02836 | |
| 0.006 | 0.546 | 0.085 | Mannosidase inhibitor | 0.085 0.008 DBMET02836 | DBMET02836 | |
| 0.007 | 0.549 | 0.081 | Alpha-mannosidase inhibitor | 0.081 0.011 DBMET02836 | DBMET02836 | |
| 0.009 | 0.554 | 0.05 | Myc inhibitor | 0.05 0.045 DBMET02836 | DBMET02836 | |
| 0.017 | 0.565 | 0.141 | Anabolic | 0.141 0.023 DBMET02836 | DBMET02836 | |
| 0.003 | 0.554 | 0.033 | NMDA receptor subunit 3A antagonist | 0.033 0.032 DBMET02836 | DBMET02836 | |
| 0.014 | 0.566 | 0.083 | Aminoacyl-tRNA synthetase inhibitor | 0.083 0.072 DBMET02836 | DBMET02836 | |
| 0.016 | 0.568 | 0.129 | Acetylcholine antagonist | 0.129 0.063 DBMET02836 | DBMET02836 | |
| 0.016 | 0.569 | 0.118 | Toll-Like receptor antagonist | 0.118 0.088 DBMET02836 | DBMET02836 | |
| 0.013 | 0.566 | 0.281 | Mediator release inhibitor | 0.281 0.008 DBMET02836 | DBMET02836 | |
| 0.016 | 0.57 | 0.136 | Cholinergic antagonist | 0.136 0.061 DBMET02836 | DBMET02836 | |
| 0.003 | 0.557 | 0.043 | Neuraminidase (Influenza B) inhibitor | 0.043 0.003 DBMET02836 | DBMET02836 | |
| 0.019 | 0.574 | 0.201 | Protein kinase stimulant | 0.201 0.041 DBMET02836 | DBMET02836 | |
| 0.021 | 0.579 | 0.108 | Acetylcholine release stimulant | 0.108 0.071 DBMET02836 | DBMET02836 | |
| 0.01 | 0.576 | 0.059 | Glutamate (mGluR group III) antagonist | 0.059 0.013 DBMET02836 | DBMET02836 | |
| 0.004 | 0.572 | 0.211 | Acyl-CoA dehydrogenase inhibitor | 0.211 0.005 DBMET02836 | DBMET02836 | |
| 0.004 | 0.575 | 0.087 | Lysophosphatidic acid 2 receptor antagonist | 0.087 0.005 DBMET02836 | DBMET02836 | |
| 0.012 | 0.584 | 0.036 | Glutamate (mGluR8) antagonist | 0.035 0.028 DBMET02836 0.036 0.023 DBMET02841 | DBMET02841 | |
| 0.005 | 0.577 | 0.04 | Toll-Like receptor 2 agonist | 0.04 0.029 DBMET02836 | DBMET02836 | |
| 0.044 | 0.617 | 0.18 | RNA-directed DNA polymerase inhibitor | 0.18 0.132 DBMET02836 | DBMET02836 | |
| 0.014 | 0.589 | 0.113 | Interleukin 1 beta converting enzyme inhibitor | 0.113 0.042 DBMET02836 | DBMET02836 | |
| 0.002 | 0.578 | 0.056 | 5-Alpha-reductase inhibitor | 0.056 0.017 DBMET02836 | DBMET02836 | |
| 0.034 | 0.612 | 0.174 | Neurotrophic factor enhancer | 0.174 0.105 DBMET02836 | DBMET02836 | |
| 0.023 | 0.602 | 0.373 | Succinate dehydrogenase inhibitor | 0.373 0.005 DBMET02836 | DBMET02836 | |
| 0.016 | 0.597 | 0.097 | Glycine receptor agonist | 0.097 0.023 DBMET02836 | DBMET02836 | |
| 0.029 | 0.612 | 0.08 | Transcription factor NF kappa B stimulant | 0.08 0.069 DBMET02836 | DBMET02836 | |
| 0.003 | 0.587 | 0.038 | 5-Alpha-reductase 2 inhibitor | 0.038 0.008 DBMET02836 | DBMET02836 | |
| 0.026 | 0.612 | 0.092 | D-Ala-D-Ala ligase inhibitor | 0.092 0.042 DBMET02836 | DBMET02836 | |
| 0.03 | 0.622 | 0.123 | Hexokinase inhibitor | 0.123 0.114 DBMET02836 | DBMET02836 | |
| 0.006 | 0.599 | 0.274 | Porphobilinogen synthase inhibitor | 0.274 0.006 DBMET02836 | DBMET02836 | |
| 0.018 | 0.613 | 0.126 | Bile acid receptor antagonist | 0.126 0.015 DBMET02836 | DBMET02836 | |
| 0.01 | 0.608 | 0.268 | Cholesterol synthesis inhibitor | 0.268 0.015 DBMET02836 | DBMET02836 | |
| 0.019 | 0.617 | 0.085 | Phosphodiesterase I inhibitor | 0.085 0.067 DBMET02836 | DBMET02836 | |
| 0.005 | 0.605 | 0.053 | Benzodiazepine antagonist | 0.053 0.021 DBMET02836 | DBMET02836 | |
| 0.006 | 0.607 | 0.047 | Membrane dipeptidase inhibitor | 0.047 0.018 DBMET02836 | DBMET02836 | |
| 0.015 | 0.617 | 0.123 | Mannose-6-phosphate isomerase inhibitor | 0.123 0.095 DBMET02836 | DBMET02836 | |
| 0.02 | 0.623 | 0.276 | NADH dehydrogenase inhibitor | 0.276 0.007 DBMET02836 | DBMET02836 | |
| 0.027 | 0.633 | 0.07 | Calcium channel P-type blocker | 0.07 0.028 DBMET02836 | DBMET02836 | |
| 0.017 | 0.624 | 0.066 | MDM2 inhibitor | 0.066 0.052 DBMET02836 | DBMET02836 | |
| 0.003 | 0.61 | 0.028 | Somatostatin 5 antagonist | 0.028 0.024 DBMET02836 | DBMET02836 | |
| 0.001 | 0.609 | 0.031 | 5-Alpha-reductase 1 inhibitor | 0.031 0.009 DBMET02836 | DBMET02836 | |
| 0.009 | 0.625 | 0.052 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.026 DBMET02836 | DBMET02836 | |
| 0.005 | 0.625 | 0.036 | Purinergic P2Y14 antagonist | 0.036 0.014 DBMET02836 | DBMET02836 | |
| 0.007 | 0.643 | 0.129 | Aminopeptidase I inhibitor | 0.129 0.017 DBMET02836 | DBMET02836 | |
| 0.008 | 0.649 | 0.122 | Glycine receptor antagonist | 0.122 0.017 DBMET02836 | DBMET02836 | |
| 0.044 | 0.687 | 0.455 | GABA C receptor rho-3 antagonist | 0.455 0.04 DBMET02836 | DBMET02836 | |
| 0.032 | 0.68 | 0.173 | Neurotensin receptor agonist | 0.173 0.059 DBMET02836 | DBMET02836 | |
| 0.011 | 0.662 | 0.058 | Phosphodiesterase 1A inhibitor | 0.058 0.047 DBMET02836 | DBMET02836 | |
| 0.004 | 0.665 | 0.043 | Glycine transporter 2 inhibitor | 0.043 0.035 DBMET02836 | DBMET02836 | |
| 0.008 | 0.669 | 0.066 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.066 0.005 DBMET02836 | DBMET02836 | |
| 0.003 | 0.667 | 0.066 | Purinergic P2Y antagonist | 0.066 0.017 DBMET02836 | DBMET02836 | |
| 0.015 | 0.685 | 0.105 | DOPA decarboxylase inhibitor | 0.105 0.066 DBMET02836 | DBMET02836 | |
| 0.001 | 0.672 | 0.057 | Uridine phosphorylase inhibitor | 0.057 0.006 DBMET02836 | DBMET02836 | |
| 0.042 | 0.712 | 0.267 | Apoptosis antagonist | 0.267 0.111 DBMET02836 | DBMET02836 | |
| 0.006 | 0.678 | 0.076 | Adenosine deaminase inhibitor | 0.076 0.011 DBMET02836 | DBMET02836 | |
| 0.005 | 0.677 | 0.248 | Psychostimulant | 0.248 0.059 DBMET02836 | DBMET02836 | |
| 0.003 | 0.675 | 0.15 | Phosphofructokinase-1 inhibitor | 0.15 0.018 DBMET02836 | DBMET02836 | |
| 0.007 | 0.683 | 0.11 | Urease inhibitor | 0.11 0.056 DBMET02836 | DBMET02836 | |
| 0.019 | 0.695 | 0.172 | Peroxidase inhibitor | 0.172 0.068 DBMET02836 | DBMET02836 | |
| 0.004 | 0.681 | 0.078 | Acetylcholine nicotinic antagonist | 0.078 0.056 DBMET02836 | DBMET02836 | |
| 0.009 | 0.686 | 0.109 | Microtubule formation inhibitor | 0.109 0.075 DBMET02836 | DBMET02836 | |
| 0.011 | 0.688 | 0.11 | Purinergic P2X1 antagonist | 0.11 0.014 DBMET02836 | DBMET02836 | |
| 0.012 | 0.689 | 0.139 | Keratolytic | 0.139 0.016 DBMET02836 | DBMET02836 | |
| 0.014 | 0.693 | 0.099 | Cell adhesion inhibitor | 0.099 0.09 DBMET02836 | DBMET02836 | |
| 0.002 | 0.681 | 0.027 | Methionyl aminopeptidase 2 inhibitor | 0.027 0.016 DBMET02836 | DBMET02836 | |
| 0.026 | 0.706 | 0.083 | Hematopoietic | 0.083 0.065 DBMET02836 | DBMET02836 | |
| 0.006 | 0.686 | 0.035 | Ceramide glucosyltransferase inhibitor | 0.035 0.027 DBMET02836 | DBMET02836 | |
| 0 | 0.683 | 0.034 | Prostaglandin EP4 agonist | 0.034 0.007 DBMET02836 | DBMET02836 | |
| 0.007 | 0.691 | 0.048 | Guanylate cyclase stimulant | 0.048 0.023 DBMET02836 | DBMET02836 | |
| 0.003 | 0.689 | 0.166 | Argininosuccinate synthase inhibitor | 0.166 0.01 DBMET02836 | DBMET02836 | |
| 0.003 | 0.69 | 0.08 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.08 0.025 DBMET02836 | DBMET02836 | |
| 0.004 | 0.692 | 0.051 | Glutamate (mGluR3) agonist | 0.051 0.005 DBMET02836 | DBMET02836 | |
| 0.002 | 0.694 | 0.054 | Farnesoid X receptor agonist | 0.054 0.013 DBMET02836 | DBMET02836 | |
| 0.009 | 0.708 | 0.228 | Creatine kinase inhibitor | 0.228 0.007 DBMET02836 | DBMET02836 | |
| 0.015 | 0.716 | 0.162 | TRPA1 agonist | 0.162 0.023 DBMET02836 | DBMET02836 | |
| 0.042 | 0.744 | 0.161 | Catenin beta inhibitor | 0.161 0.082 DBMET02836 | DBMET02836 | |
| 0.015 | 0.717 | 0.108 | Granulocyte macrophage colony stimulating factor agonist | 0.108 0.026 DBMET02836 | DBMET02836 | |
| 0.013 | 0.716 | 0.052 | Factor III inhibitor | 0.052 0.029 DBMET02836 | DBMET02836 | |
| 0.011 | 0.721 | 0.18 | Glutamate dehydrogenase inhibitor | 0.18 0.012 DBMET02836 | DBMET02836 | |
| 0.002 | 0.714 | 0.079 | GABA uptake inhibitor | 0.079 0.005 DBMET02836 | DBMET02836 | |
| 0.004 | 0.72 | 0.125 | Phenylalanine 4-hydroxylase inhibitor | 0.125 0.017 DBMET02836 | DBMET02836 | |
| 0.016 | 0.733 | 0.151 | Melanin inhibitor | 0.151 0.08 DBMET02836 | DBMET02836 | |
| 0.007 | 0.729 | 0.057 | Protein 50S ribosomal subunit inhibitor | 0.057 0.033 DBMET02841 | DBMET02841 | |
| 0.001 | 0.725 | 0.048 | Phosphoglycerate kinase inhibitor | 0.048 0.015 DBMET02836 | DBMET02836 | |
| 0.011 | 0.737 | 0.157 | Cathepsin H inhibitor | 0.157 0.041 DBMET02836 | DBMET02836 | |
| 0.007 | 0.733 | 0.146 | Mucolytic | 0.146 0.035 DBMET02836 | DBMET02836 | |
| 0.003 | 0.73 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 DBMET02836 | DBMET02836 | |
| 0.039 | 0.767 | 0.187 | Ca2+-transporting ATPase inhibitor | 0.187 0.005 DBMET02836 | DBMET02836 | |
| 0.001 | 0.73 | 0.032 | Kainate receptor 1 antagonist | 0.032 0.009 DBMET02836 | DBMET02836 | |
| 0.003 | 0.733 | 0.271 | Alcohol oxidase inhibitor | 0.271 0.005 DBMET02836 | DBMET02836 | |
| 0.009 | 0.742 | 0.14 | Neuropeptide Y1 antagonist | 0.14 0.082 DBMET02836 | DBMET02836 | |
| 0.051 | 0.784 | 0.161 | Heat shock protein 70 antagonist | 0.161 0.026 DBMET02836 | DBMET02836 | |
| 0.007 | 0.749 | 0.189 | GABA C receptor antagonist | 0.189 0.015 DBMET02836 | DBMET02836 | |
| 0.007 | 0.755 | 0.095 | GABA B receptor agonist | 0.095 0.02 DBMET02836 | DBMET02836 | |
| 0.016 | 0.764 | 0.17 | GABA C receptor rho-2 antagonist | 0.17 0.051 DBMET02836 | DBMET02836 | |
| 0.004 | 0.753 | 0.051 | Nicotinic acid receptor 2 agonist | 0.051 0.013 DBMET02836 | DBMET02836 | |
| 0.011 | 0.76 | 0.094 | Glutamate (mGluR6) antagonist | 0.094 0.013 DBMET02836 | DBMET02836 | |
| 0.028 | 0.781 | 0.114 | Glutamate release inhibitor | 0.114 0.026 DBMET02836 | DBMET02836 | |
| 0.003 | 0.756 | 0.161 | Glutamate decarboxylase inhibitor | 0.161 0.011 DBMET02836 | DBMET02836 | |
| 0.013 | 0.771 | 0.339 | Antibacterial | 0.339 0.108 DBMET02836 0.287 0.146 DBMET02841 0.246 0.181 DBMET02844 | DBMET02836 | |
| 0.005 | 0.763 | 0.129 | Expectorant | 0.129 0.045 DBMET02836 | DBMET02836 | |
| 0.007 | 0.768 | 0.258 | GABA C receptor agonist | 0.258 0.013 DBMET02836 | DBMET02836 | |
| 0.001 | 0.77 | 0.032 | Nicotinic acid receptor 2 antagonist | 0.032 0.011 DBMET02836 | DBMET02836 | |
| 0.005 | 0.774 | 0.146 | GABA aminotransferase inhibitor | 0.146 0.009 DBMET02836 | DBMET02836 | |
| 0.021 | 0.795 | 0.33 | Interleukin agonist | 0.33 0.035 DBMET02836 | DBMET02836 | |
| 0.007 | 0.785 | 0.213 | UDP-glucose 4-epimerase inhibitor | 0.213 0.016 DBMET02836 | DBMET02836 | |
| 0.006 | 0.786 | 0.149 | Falcipain 3 inhibitor | 0.149 0.037 DBMET02836 | DBMET02836 | |
| 0.009 | 0.794 | 0.115 | Potassium channel (Ca-activated) activator | 0.115 0.044 DBMET02836 | DBMET02836 | |
| 0.006 | 0.791 | 0.076 | Phospholipase D inhibitor | 0.076 0.041 DBMET02836 | DBMET02836 | |
| 0.005 | 0.792 | 0.041 | Kainate receptor agonist | 0.041 0.029 DBMET02836 | DBMET02836 | |
| 0.003 | 0.791 | 0.053 | Carbamoyl phosphate synthetase inhibitor | 0.053 0.051 DBMET02836 | DBMET02836 | |
| 0.003 | 0.791 | 0.111 | Aconitate hydratase inhibitor | 0.111 0.007 DBMET02836 | DBMET02836 | |
| 0.007 | 0.797 | 0.422 | Alpha-N-acetylglucosaminidase inhibitor | 0.422 0.008 DBMET02836 | DBMET02836 | |
| 0.007 | 0.797 | 0.156 | GABA C receptor rho-1 antagonist | 0.156 0.019 DBMET02836 | DBMET02836 | |
| 0.006 | 0.803 | 0.175 | I kappa B kinase epsilon inhibitor | 0.175 0.094 DBMET02836 | DBMET02836 | |
| 0.001 | 0.803 | 0.066 | Guanylate cyclase inhibitor | 0.066 0.007 DBMET02836 | DBMET02836 | |
| 0.004 | 0.807 | 0.145 | Cytidine deaminase inhibitor | 0.145 0.079 DBMET02836 | DBMET02836 | |
| 0.001 | 0.804 | 0.036 | Fumarate hydratase inhibitor | 0.036 0.022 DBMET02836 | DBMET02836 | |
| 0.005 | 0.816 | 0.036 | Glutamate (mGluR8) agonist | 0.036 0.03 DBMET02836 | DBMET02836 | |
| 0.002 | 0.814 | 0.114 | Biliverdin reductase inhibitor | 0.114 0.015 DBMET02836 | DBMET02836 | |
| 0.005 | 0.821 | 0.248 | Ferrochelatase inhibitor | 0.248 0.013 DBMET02836 | DBMET02836 | |
| 0.005 | 0.826 | 0.126 | Cystathionine beta-synthase inhibitor | 0.126 0.054 DBMET02836 | DBMET02836 | |
| 0.004 | 0.826 | 0.153 | Anticonvulsant | 0.153 0.125 DBMET02836 | DBMET02836 | |
| 0.002 | 0.833 | 0.066 | Dihydroorotase inhibitor | 0.066 0.013 DBMET02836 | DBMET02836 | |
| 0.041 | 0.872 | 0.166 | Nitric-oxide synthase stimulant | 0.166 0.162 DBMET02836 | DBMET02836 | |
| 0.009 | 0.85 | 0.166 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.166 0.022 DBMET02836 | DBMET02836 | |
| 0.002 | 0.852 | 0.119 | Histidine decarboxylase inhibitor | 0.119 0.026 DBMET02836 | DBMET02836 | |
| 0.002 | 0.852 | 0.048 | Glutamate (mGluR3) antagonist | 0.048 0.014 DBMET02836 | DBMET02836 | |
| 0.001 | 0.857 | 0.045 | TRPM8 blocker | 0.045 0.019 DBMET02836 | DBMET02836 | |
| 0.003 | 0.866 | 0.065 | Pregnane X receptor antagonist | 0.065 0.021 DBMET02836 | DBMET02836 | |
| 0.003 | 0.869 | 0.029 | NMDA 2D receptor antagonist | 0.029 0.017 DBMET02836 | DBMET02836 | |
| 0.033 | 0.912 | 0.321 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.321 0.186 DBMET02836 | DBMET02836 | |
| 0.007 | 0.893 | 0.162 | Cell wall synthesis inhibitor | 0.162 0.055 DBMET02836 | DBMET02836 | |
| 0.001 | 0.889 | 0.058 | NMDA 2C receptor antagonist | 0.058 0.047 DBMET02836 | DBMET02836 | |
| 0.002 | 0.891 | 0.069 | Nicotinic acid receptor agonist | 0.069 0.009 DBMET02836 | DBMET02836 | |
| 0.005 | 0.917 | 0.301 | DNA synthesis inhibitor | 0.301 0.043 DBMET02836 | DBMET02836 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |